Bio, Inc. (THRD) has experienced a notable downturn, touching a 52-week low of $5.58. This latest price point reflects a significant retreat from more favorable positions over the past year, with the ...

The readout comes on the heels of CagriSema’s disappointing Phase III performance, where it missed Novo’s projection of 25% ...

Experimental fungi and ‘robotic bees’ are among the ag-tech innovations being trialled in a country on the frontline of ...

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...

Yet, in a 25,000-square-foot West Dallas laboratory, dozens of geneticists, biologists, AI experts and more work day in and ...

Discover how biohackers are using science to optimize their bodies and minds, and why medical professionals say some of these techniques actually work.

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...

There are some parents who ask for the child’s consent to post a photo of them on social media. Then there are parents like ...

Mura Technology's Hydro-PRT advanced plastic recycling process is now included in the ecoinvent life cycle inventory database ...

Keith Hale has been appointed as group CEO of Titian Software and Labguru (BioData Inc.), two providers of laboratory data ...

U.S. authorities have indicted five people over their alleged involvement in a multi-year North Korean IT worker scheme that ...